News

Its proximity to Earth – about 50 to 70 million kilometers from mid to late April – means we catch more of its light, so it ...
In a report released today, Chris Quintero from Morgan Stanley maintained a Buy rating on Vertex (VERX – Research Report), with a price target ...
A life sciences company is setting up shop in Durham to take advantage of the area's robust talent pool and thriving biotech ...
Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...
BOSTON, April 11, 2025--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Paul Negulescu, Ph.D. Senior Vice President, Vertex has been awarded the 2025 Canada Gairdner ...
Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 have been able to come off insulin altogether within a year, raising the prospect of a life without ...
With travel warnings and revoked visas, the two superpowers locked in a bruising trade war may make students and tourists their bargaining chips. By Vivian Wang Reporting from Beijing China has ...
Myanmar: 4 Indians trapped in Myawaddy scam repatriated, Embassy issues warning NAYPYITAW: The Indian Embassy in Myanmar on Friday said that four Indian nationals who were victims of scam ...
The bipartisan bill would make accounting part of STEM, a federally funded program for science, technology, engineering, and mathematics education.